MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?

Lung cancer is a commonly diagnosed cancer and the leading cause of cancer-related deaths, posing a serious health risk. Despite new advances in immune checkpoint and targeted therapies in recent years, the prognosis for lung cancer patients, especially those in advanced stages, remains poor. MicroR...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Han, Liu, Yufang, Chen, Longqing, Zhao, Juanjuan, Guo, Mengmeng, Zhao, Xu, Wen, Zhenke, He, Zhixu, Chen, Chao, Xu, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295928/
https://www.ncbi.nlm.nih.gov/pubmed/37371458
http://dx.doi.org/10.3390/biom13060877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295928/
https://www.ncbi.nlm.nih.gov/pubmed/37371458
http://dx.doi.org/10.3390/biom13060877

Ejemplares similares